Regulation of peroxisome proliferator-activated receptor-α expression during lung inflammation

被引:34
|
作者
Becker, Julien [1 ]
Delayre-Orthez, Carine [1 ]
Frossard, Nelly [1 ]
Pons, Francoise [1 ]
机构
[1] Univ Louis Pasteur Strasbourg 1, Fac Pharm, EA Inflammat & Environm Asthme 3771, F-67401 Illkirch Graffenstaden, France
关键词
PPAR alpha; Inflammation; Acute lung injury; Asthma; Tumor necrosis factor-alpha; Lipopolysaccharide; Fenofibrate; Dexamethasone; Lung; Mouse;
D O I
10.1016/j.pupt.2007.08.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peroxisome proliferator-activated receptor-alpha (PPAR alpha) is implicated in the control of airway inflammation. However, little is known so far about PPAR alpha expression and regulation in the lung. Our aim was to assess PPAR alpha expression in the lung from normal mice, as well as to investigate its regulation during airway inflammation or in response to anti-inflammatory agents. The PPAR alpha activator, fenofibrate, the glucocorticoid, dexamethasone or vehicle was administered to normal mice, to mice exposed to tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) or to ovalbumin (OVA)-sensitized and challenged animals. PPAR alpha expression was assessed by quantifying PPAR alpha mRNA levels using real-time quantitative PCR after reverse-transcription of total lung RNA. Airway inflammation was evaluated by determining total and differential cell counts, as well as TNF-alpha production in bronchoalveolar lavage fluids. PPAR alpha mRNA was found at significant levels in the lung from normal mice. This expression was increased by 65% (p<0.05) and 55% (p<0.05) in animals treated with fenofibrate and dexamethasone, respectively. In mice exposed to TNF-alpha or LPS, as well as in animals sensitized and challenged with OVA, that exhibited airway inflammation, PPAR alpha mRNA was decreased by 60% (p<0.05), 43% (p<0.05) and 50% (p<0.05), respectively. In mice exposed to LPS, down-regulation of PPAR alpha was maximal at 4 h, whereas TNF-alpha production and cell infiltration peaked at 2 and 24 h, respectively. In the lung of mice exposed to LPS or OVA and treated with fenofibrate or dexamethasone, PPAR alpha down-regulation was suppressed, while airway inflammation was abolished. Our data showed that PPAR alpha is constitutively expressed in mouse lung and down-regulated in response to TNF-alpha or upon acute or allergic airway inflammation. Fenofibrate and dexamethasone upregulated PPAR alpha in normal lung and suppressed PPAR alpha down-regulation associated with airway inflammation. Taken together, our data show that PPARalpha expression is inversely regulated with lung inflammation. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:324 / 330
页数:7
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor-γ expression in lung
    Inoue, K
    Kawahito, Y
    Sano, H
    [J]. CHEST, 2002, 122 (01) : 386 - 387
  • [2] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [3] Regulation of macrophage gene expression by the peroxisome proliferator-activated receptor-γ
    Ricote, M
    Welch, JS
    Glass, CK
    [J]. HORMONE RESEARCH, 2000, 54 (5-6) : 275 - 280
  • [4] Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
    Bishop-Bailey, David
    Bystrom, Jonas
    [J]. PHARMACOLOGY & THERAPEUTICS, 2009, 124 (02) : 141 - 150
  • [5] Regulation of Peroxisome Proliferator-Activated Receptor-γ Expression in Human Eosinophils by Estradiol
    Ueki, Shigeharu
    Oguma, Mariko
    Usami, Atsuko
    Kamada, Yumiko
    Kato, Hikari
    Kamada, Rie
    Takeda, Masahide
    Ito, Wataru
    Tanigai, Tomomi
    Kayaba, Hiroyuki
    Chihara, Junichi
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2009, 149 : 51 - 56
  • [6] Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis
    Yang, Liu
    Chan, Che-Chang
    Kwon, Oh-Sang
    Liu, Songling
    McGhee, Jason
    Stimpson, Stephen A.
    Chen, Lihong Z.
    Harrington, W. Wallace
    Symonds, William T.
    Rockey, Don C.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (05): : G902 - G911
  • [7] The role of the peroxisome proliferator-activated receptor-α (PPAR-α) in the regulation of acute inflammation
    Cuzzocrea, Salvatore
    Mazzon, Emanuela
    Di Paola, Rosanna
    Peli, Angelo
    Bonato, Andrea
    Britti, Domenico
    Genovese, Tiziana
    Muia, Carmelo
    Crisafulli, Concetta
    Caputi, Achille P.
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 79 (05) : 999 - 1010
  • [8] CIS-DICHLORODIAMMINEPLATINUM UPREGULATES THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AND ENHANCES THE CYTOTOXICITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONIST
    Tanaka, Nobuyuki
    Miyajima, Akira
    Hasegawa, Masanori
    Shirotake, Suguru
    Kosaka, Takeo
    Kikuchi, Eiji
    Oya, Mototsugu
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E379 - E379
  • [9] The peroxisome proliferator-activated receptor-γ agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-α- dependent manner in vitro and in vivo in mice
    Orasanu, Gabriela
    Ziouzenkova, Ouliana
    Devchand, Pallavi R.
    Nehra, Vedika
    Hamdy, Osama
    Horton, Edward S.
    Plutzky, Jorge
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (10) : 869 - 881
  • [10] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    [J]. FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462